Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1796027

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1796027

Sterile Vials

PUBLISHED:
PAGES: 481 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Sterile Vials Market to Reach US$10.0 Billion by 2030

The global market for Sterile Vials estimated at US$6.7 Billion in the year 2024, is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Sterile Empty Vial, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in the Sterile Liquid Filled Vial segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 10.5% CAGR

The Sterile Vials market in the U.S. is estimated at US$1.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Sterile Vials Market - Key Trends & Drivers Summarized

Why Are Sterile Vials at the Center of Pharmaceutical & Biotech Evolution?

Sterile vials-hermetically sealed glass or plastic containers used to store injectable drugs, vaccines, and biologics-are indispensable in the pharmaceutical supply chain. Their role in ensuring drug stability, sterility, and controlled dosage delivery has grown exponentially with the rise of biologics, personalized medicine, and large-scale vaccination efforts. Unlike standard packaging containers, sterile vials must meet stringent regulatory, microbiological, and physicochemical standards to maintain product efficacy and patient safety. This is especially critical in applications such as monoclonal antibodies, gene therapies, and RNA-based drugs, where contamination or packaging-induced degradation can compromise clinical outcomes.

Glass vials, particularly Type I borosilicate, dominate the market due to their chemical resistance and thermal stability. However, concerns over breakage, delamination, and leachable elements have accelerated interest in advanced polymer-based alternatives. These plastic vials offer advantages such as reduced particulate risk, lightweight design, and higher impact resistance-especially relevant for high-throughput fill-finish operations. The sterile vial market is now characterized by high-precision manufacturing, cleanroom automation, and container closure integrity testing-all of which serve the pharmaceutical industry's uncompromising demand for safety, consistency, and scalability.

How Are Innovations in Materials and Processes Redefining Sterile Vial Production?

Advancements in vial manufacturing are pushing the envelope in terms of purity, dimensional stability, and scalability. Laser-etching and camera-based inspection systems now provide 100% traceability, while integrated fill-finish lines combine washing, depyrogenation, filling, and capping under sterile, isolator-controlled conditions. This minimizes human intervention and contamination risk. New washing protocols and low-endotoxin formulations ensure that sterile vials meet strict thresholds for injectable-grade use, while advanced lyophilization-compatible designs support freeze-drying processes required for vaccines and biologics.

Material innovation is equally pivotal. While glass remains dominant, the rise of cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) vials presents new frontiers. These polymers offer excellent transparency, dimensional accuracy, and low extractables, making them suitable for sensitive biologics and high-purity injectable formulations. They’re also compatible with gamma and e-beam sterilization methods, broadening options for aseptic processing. Meanwhile, blow-fill-seal (BFS) technology is gaining ground in unit-dose delivery formats, allowing the sterile formation and sealing of vials in a single step-particularly useful in high-volume vaccine and ophthalmic applications.

How Are End-Use Patterns Shaping Demand for Sterile Vials?

Pharmaceutical and biotech companies are the primary consumers of sterile vials, particularly for parenteral drug delivery. The growing prevalence of chronic diseases and the surge in biologics-many of which require cold-chain preservation and aseptic packaging-have driven demand for sterile packaging solutions that offer high barrier protection and thermal resilience. Hospitals and compounding pharmacies also use sterile vials for customized admixtures, anesthetics, and diagnostic reagents.

The impact of pandemic preparedness and global immunization programs cannot be overstated. Sterile vials played a pivotal role in the deployment of COVID-19 vaccines, spotlighting the need for scalable, GMP-compliant manufacturing lines and robust cold-chain packaging. As nations build long-term stockpiles and booster programs become normalized, demand for sterile vials continues to escalate-not just in developed markets but across emerging economies as well.

Veterinary medicine, contract manufacturing organizations (CMOs), and research laboratories represent other critical end users. These segments value flexibility in batch sizes, compatibility with high-potency APIs, and ease of integration into existing sterile fill-finish lines. Additionally, the rise of patient-centric dosing formats-such as self-administered injectables-is spurring interest in pre-filled sterile vial formats that simplify handling and minimize exposure risk.

What’s Driving the Growth in the Sterile Vials Market?

The growth in the sterile vials market is driven by several factors centered around advancements in vial materials, aseptic manufacturing technologies, and shifts in pharmaceutical delivery models. On the materials front, innovations in polymer vial technologies-especially those that reduce extractables and offer break resistance-are expanding usage beyond conventional glass. These new formats are particularly attractive for high-value biologics and sensitive formulations, where even trace contaminants can alter efficacy.

In terms of manufacturing technology, the proliferation of robotic, isolator-based fill-finish systems ensures sterile vial production with minimal human intervention, complying with cGMP and Annex 1 guidelines. These systems offer real-time environmental monitoring, automated decontamination, and container closure integrity verification-making them vital for high-throughput, low-defect processing. Integration of serialization, RFID tagging, and camera vision systems supports full traceability and anti-counterfeiting compliance.

End-use expansion plays an equally crucial role. The shift toward complex biologics, personalized therapies, and next-gen vaccines-many of which are temperature-sensitive or require multi-dose regimens-demands packaging formats that maintain integrity under cold chain and extended storage. The rise of CDMOs and decentralized clinical trials is also increasing demand for sterile vials in smaller, more flexible batch sizes. Regulatory mandates around sterility assurance and serialization further elevate the need for precision-engineered packaging solutions.

Together, these technology-driven and industry-aligned trends are powering sustained and high-value growth in the global sterile vials market.

SCOPE OF STUDY:

The report analyzes the Sterile Vials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Sterile Empty Vial, Sterile Liquid Filled Vial, Individual Sterilized Components); Material (Glass Material, Plastic Material); Volume (Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume, 10 - 20 ml Volume, Above 20 ml Volume); End-User (Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Acme Vial and Glass Company, LLC
  • Adelphi Healthcare Packaging
  • APG Europe
  • Bormioli Pharma S.p.A.
  • Corning Incorporated
  • Dalton Pharma Services
  • DWK Life Sciences GmbH
  • Gerresheimer AG
  • Kishore Group
  • Nipro Corporation
  • O.Berk Company
  • Pacific Vial Manufacturing, Inc.
  • Piramal Glass (Piramal Enterprises Ltd.)
  • Qorpak
  • SCHOTT AG
  • SGD Pharma
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Stevanato Group S.p.A.
  • Thermo Fisher Scientific
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP39384

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Sterile Vials - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Biologics and Injectable Drug Development Pipelines Propels Demand for Sterile Vial Packaging
    • Expansion of Fill-Finish Contract Manufacturing Services Strengthens Market for Ready-to-Use Vials
    • Strict Regulatory Requirements for Sterility and Contamination Control Drive Quality Upgrades
    • Increased Vaccine and Antibody Therapy Production Expands Addressable Market Volume
    • Adoption of Blow-Fill-Seal and RTU Technologies Accelerates Modernization of Packaging Lines
    • Growth in Personalized Medicine and Small-Batch Drug Production Spurs Flexible Packaging Demand
    • Rising Penetration of Prefilled Systems Enhances Compatibility Requirements for Vial Design
    • Pharma Outsourcing and Global Supply Chain Diversification Generate Consistent Vial Demand
    • Development of High-Value Biologics Strengthens Need for Chemically Inert and Durable Vials
    • Emerging Markets Regulatory Harmonization Opens Opportunities for Global Vial Manufacturers
    • Focus on Cold Chain Integrity Drives Demand for Freeze-Resistant and Thermally Stable Vials
    • Integration of Serialization and Track-and-Trace Capabilities Enhances Packaging Compliance
    • Adoption of Automation in Aseptic Processing Lines Spurs Compatibility with Standardized Vial Formats
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sterile Vials Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sterile Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sterile Empty Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sterile Empty Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Sterile Empty Vial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sterile Liquid Filled Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sterile Liquid Filled Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Sterile Liquid Filled Vial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Individual Sterilized Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Individual Sterilized Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Individual Sterilized Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Above 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Above 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Above 20 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Below 2 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Below 2 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Below 2 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 2 - 5 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for 2 - 5 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for 2 - 5 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for 5 - 10 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for 5 - 10 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for 5 - 10 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for 10 - 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for 10 - 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for 10 - 20 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Clinical Labs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Compounding Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Compounding Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Compounding Labs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Biopharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Biopharmaceutical Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for CMOs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for CMOs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for CMOs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Glass Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Glass Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Glass Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Plastic Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Plastic Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Plastic Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • JAPAN
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • CHINA
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: China 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: China 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: China 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: China 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • EUROPE
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Sterile Vials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • FRANCE
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 113: France Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: France 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: France 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: France 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: France 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • GERMANY
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 149: UK Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Spain 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Spain 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Spain 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Spain 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Russia 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Russia 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Russia 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Russia 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Sterile Vials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Australia 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Australia 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Australia 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Australia 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • INDIA
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 224: India Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: India 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: India 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 230: India Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: India 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: India 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: South Korea 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: South Korea 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: South Korea 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: South Korea 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Sterile Vials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Latin America 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Latin America 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Latin America 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Latin America 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Argentina 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Argentina 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Argentina 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Argentina 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Brazil 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Brazil 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Brazil 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Brazil 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Mexico 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Mexico 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Mexico 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Mexico 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Sterile Vials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 325: Middle East 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 328: Middle East 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 331: Middle East 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 334: Middle East 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 340: Iran 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 343: Iran 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 346: Iran 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 349: Iran 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 352: Israel 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 355: Israel 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 358: Israel 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 361: Israel 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 376: UAE 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 379: UAE 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 382: UAE 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 385: UAE 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
  • AFRICA
    • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 400: Africa 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 403: Africa 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 406: Africa 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 409: Africa 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!